Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Edgar L. Hill"'
Autor:
Sebastian Molnar, Stephen Whitney, S. Munir Alam, Lindsay Wieczorek, Leonard Maboko, Nelson L. Michael, Merlin L. Robb, Susan Zolla-Pazner, Gary R. Matyas, Mary A. Marovich, Francine E. McCutchan, Carlos G. Moscoso, Shelly J. Krebs, Michael Pensiero, Barton F. Haynes, Vincent Dussupt, R. Holland Cheng, Bonnie M. Slike, Michael Hoelscher, Sodsai Tovanabutra, Thomas C. VanCott, Victoria R. Polonis, Eric Sanders-Buell, Shawyon Malek-Salehi, Tina Tong, Vaniambadi S. Kalyanaraman, Carl R. Alving, Mangala Rao, Constance Williams, Agnès L. Chenine, Edgar L. Hill, Hua-Xin Liao
Publikováno v:
Journal of virology, vol 89, iss 15
Eliciting broadly reactive functional antibodies remains a challenge in human immunodeficiency virus type 1 (HIV-1) vaccine development that is complicated by variations in envelope (Env) subtype and structure. The majority of new global HIV-1 infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4202bc76deb33edda04e54292312b2b8
https://escholarship.org/uc/item/9zt603qp
https://escholarship.org/uc/item/9zt603qp
Autor:
Anna Wald, Gray Davis, Edgar L. Hill, Dan McClernon, Stacy Selke, Rachna Gupta, Lawrence Corey
Publikováno v:
The Journal of Infectious Diseases. 192:1102-1107
Background Despite widespread use of acyclovir, infection with acyclovir-resistant herpes simplex virus type 2 (HSV-2) remains uncommon. To understand the frequency and clinical significance of acyclovir-resistant isolates, we evaluated the in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47da13981006ef831ab7494122f6ce3a
https://doi.org/10.1086/432766
https://doi.org/10.1086/432766
Publikováno v:
The Journal of Infectious Diseases. 178:1616-1622
Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645adcc69e3c4974a79614a564af262d
https://doi.org/10.1086/314486
https://doi.org/10.1086/314486
Publikováno v:
Journal of Infectious Diseases. 178:297-303
Phenotypic and genotypic analyses were done on 30 acyclovir-resistant and 5 acyclovir-susceptible herpes simplex virus (HSV) isolates (22 HSV type 1 and 13 HSV type 2) recovered from 24 subjects. All isolates were susceptible to foscarnet. The phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79688c046dd64cc7187b777b13196579
https://doi.org/10.1086/515626
https://doi.org/10.1086/515626
Autor:
Alan Hay, Stephen A. Spector, David W. Kimberlin, Richard J. Whitley, Douglas L. Mayers, Karen K. Biron, Edgar L. Hill
Publikováno v:
Antiviral Research. 26:403-413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5c4da74a4b182d79a5b34373c73f85
https://doi.org/10.1016/0166-3542(95)00028-k
https://doi.org/10.1016/0166-3542(95)00028-k
Publikováno v:
Journal of Infectious Diseases. 169:1338-1341
Questions have arisen regarding the clinical outcome and the possible selection of resistant virus when patients with genital herpes discontinue prolonged chronic acyclovir; 239 immunocompetent patients with a history of frequently recurring genital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25d84b86000b8f827d7d70271f0f3164
https://doi.org/10.1093/infdis/169.6.1338
https://doi.org/10.1093/infdis/169.6.1338
Publikováno v:
New England Journal of Medicine. 329:1777-1782
Acyclovir has been widely used over the past decade as an effective and safe drug for the treatment of infections with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)1. Resistance to acyclovir was initially noted only in studies of HSV infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a5017660bec12486781c69a4f08b2d
https://doi.org/10.1056/nejm199312093292405
https://doi.org/10.1056/nejm199312093292405
Publikováno v:
Journal of Medical Virology. 41:146-149
Inhibitors of the ribonucleotide reductase of herpes simplex viruses (HSV) potentiate the activity of acyclovir in vitro and in animal studies. In addition, the combination of the ribonucleotide reductase inhibitor 348U87 and acyclovir has synergisti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e6253b90c922adc5d4a4a8544daad7
https://doi.org/10.1002/jmv.1890410528
https://doi.org/10.1002/jmv.1890410528
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:2322-2328
A total of 100 herpes simplex viruses isolated from lesions not responding to acyclovir (ACV) therapy were recovered from 51 patients infected with human immunodeficiency virus. In vitro analysis of these isolates included testing their susceptibilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2eaccac03dde7e13b0274a91671fc5
https://doi.org/10.1128/aac.35.11.2322
https://doi.org/10.1128/aac.35.11.2322
Autor:
Christine M. Posavad, Wendell Lawrence, David M. Koelle, Susan M. Swetter, Edgar L. Hill, Earl R. Kern, Sharon Safrin
Publikováno v:
Europe PubMed Central
A 34-year-old healthy woman presented with a 15-month history of persistent, nonhealing vulvar ulcerations due to herpes simplex virus (HSV) type 2. Extensive dermatologic workup and serial skin biopsies failed to reveal an underlying vulvar dermatos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84495030935df051de3f28fa4e11d3ef
https://pubmed.ncbi.nlm.nih.gov/9498430
https://pubmed.ncbi.nlm.nih.gov/9498430